The Outcomes of Concomitant Chemoradiotherapy Followed by Adjuvant Chemotherapy with Temozolomide for Newly Diagnosed High Grade Gliomas : The Preliminary Results of Single Center Prospective Study.
Jung Won Choi, Min Mi Lee, In Ah Kim, Jee Hyun Kim, Gheeyoung Choe, Chae Yong Kim
J Korean Neurosurg Soc. 2008;44(4):222-227.     DOI:
Citations to this article as recorded by Crossref logo
A Systematic Review and Meta-Analysis on the Number of Adjuvant Temozolomide Cycles in Newly Diagnosed Glioblastoma
Fahimeh Attarian, Farzad Taghizadeh-Hesary, Azar Fanipakdel, Seyed Alireza Javadinia, Pejman Porouhan, Babak PeyroShabany, Danial Fazilat-Panah
Frontiers in Oncology.2021;[Epub]     CrossRef
Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study)
Kihwan Hwang, Tae Min Kim, Chul-Kee Park, Jong Hee Chang, Tae-Young Jung, Jin Hee Kim, Do-Hyun Nam, Se-Hyuk Kim, Heon Yoo, Yong-Kil Hong, Eun-Young Kim, Dong-Eun Lee, Jungnam Joo, Yu Jung Kim, Gheeyoung Choe, Byung Se Choi, Seok-Gu Kang, Jeong Hoon Kim, C
Cancer Research and Treatment.2020; 52(2): 505.     CrossRef
MRI during radiotherapy of glioblastoma
C. Leitzen, T. Wilhelm-Buchstab, L. C. Schmeel, S. Garbe, S. Greschus, T. Müdder, S. Oberste-Beulmann, B. Simon, H. H. Schild, H. Schüller
Strahlentherapie und Onkologie.2016; 192(7): 481.     CrossRef
Validation of the Effectiveness and Safety of Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas: 10-year Experience of a Single Institution
Jin-Deok Joo, Hansol Kim, Young-Hoon Kim, Jung Ho Han, Chae-Yong Kim
Journal of Korean Medical Science.2015; 30(11): 1597.     CrossRef
Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas : A Prospective Multicenter Study of Korean Patients
Jin-Deok Joo, Jong Hee Chang, Jeong Hoon Kim, Yong-Kil Hong, Young-Hoon Kim, Chae-Yong Kim
Journal of Korean Neurosurgical Society.2012; 52(2): 92.     CrossRef
Clinical and biological significance of Nemo-like kinase expression in glioma
Gang Cui, Zhen Li, Bai Shao, Li Zhao, Yanfeng Zhou, Ting Lu, Junxiang Wang, Xioayong Shi, Jinjin Wang, Gang Zuo, Weiwei Zhu, Aiguo Shen
Journal of Clinical Neuroscience.2011; 18(2): 271.     CrossRef
Temozolomide for malignant primary spinal cord glioma: an experience of six cases and a literature review
Wook-Ha Kim, Sang Hoon Yoon, Chae-Yong Kim, Ki-jeong Kim, Min Mi Lee, Gheeyoung Choe, In-Ah Kim, Jee Hyun Kim, Yu Jung Kim, Hyun-Jib Kim
Journal of Neuro-Oncology.2011; 101(2): 247.     CrossRef
Temozolomide during and after radiation therapy for WHO grade III gliomas: preliminary report of a prospective multicenter study
Young-Hoon Kim, Chul-Kee Park, Won Ho Cho, In Ah Kim, Seyoung Moon, Gheeyoung Choe, Sung-Hye Park, Il Han Kim, Dong Gyu Kim, Hee-Won Jung, Min Mi Lee, So Hyun Bae, Seung Heon Cha, Chae-Yong Kim
Journal of Neuro-Oncology.2011; 103(3): 503.     CrossRef
Prognoseeinschätzung durch MR-Verlaufskontrollen während der Strahlentherapie bei Glioblastom-Patienten
Christina Leitzen, Hans H. Schild, Birgitta Bungart, Ulrich Herrlinger, Christiana Lütter, Thomas Müdder, Timo Wilhelm-Buchstab, Heinrich Schüller
Strahlentherapie und Onkologie.2010; 186(12): 681.     CrossRef
Clinical and biological significance of forkhead class box O 3a expression in glioma: mediation of glioma malignancy by transcriptional regulation of p27kip1
Jinlong Shi, Li Zhang, Aiguo Shen, Jianguo Zhang, Yuchan Wang, Yueming Zhao, Lin Zou, Qing Ke, Fei He, Ping Wang, Chun Cheng, Gongshen Shi
Journal of Neuro-Oncology.2010; 98(1): 57.     CrossRef
A prospective study of temozolomide plus thalidomide during and after radiation therapy for pediatric diffuse pontine gliomas: preliminary results of the Korean Society for Pediatric Neuro-Oncology study
Chae-Yong Kim, Seung-Ki Kim, Ji Hoon Phi, Min Mi Lee, In Ah Kim, Il Han Kim, Kyu-Chang Wang, Hye-Lim Jung, Mee Jeong Lee, Byung-Kyu Cho
Journal of Neuro-Oncology.2010; 100(2): 193.     CrossRef
Combined Radio- and Chemotherapy of Brain Tumours in Adult Patients
C. Nieder, M.P. Mehta, R. Jalali
Clinical Oncology.2009; 21(7): 515.     CrossRef